Remote jobs at Amandala Neuro
Developing the next generation of short-acting psychedelic treatments
About Amandala Neuro
We are a clinical-stage biopharmaceutical company spun out of the strategic combination of Beckley Psytech and Atai Life Sciences in 2025, advancing lead asset ELE-101. We develop patient-centered psychedelic treatments designed to fit the psychiatric care model and address unmet need in mental health.
Mission and direction
Amandala Neuro is a clinical-stage biopharmaceutical company developing patient-centered psychedelic medicines for neuropsychiatric conditions. Built from the strategic combination of Beckley Psytech and Atai Life Sciences, the company focuses on advancing clinically validated treatments that can be integrated into psychiatric care, with lead asset ELE-101 and a pipeline of follow-on candidates addressing unmet mental health needs.
Company values
- Patient-centered
- Scientific rigor
- Innovation
- Quality focus
- Collaboration
- Integrity
- Continuous improvement